IL103057A - A method of producing a gene that encodes the plant toxin galonin and a gene created by the method - Google Patents

A method of producing a gene that encodes the plant toxin galonin and a gene created by the method

Info

Publication number
IL103057A
IL103057A IL10305792A IL10305792A IL103057A IL 103057 A IL103057 A IL 103057A IL 10305792 A IL10305792 A IL 10305792A IL 10305792 A IL10305792 A IL 10305792A IL 103057 A IL103057 A IL 103057A
Authority
IL
Israel
Prior art keywords
gene
dna
sequence
gelonin
expression
Prior art date
Application number
IL10305792A
Other languages
English (en)
Hebrew (he)
Other versions
IL103057A0 (en
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of IL103057A0 publication Critical patent/IL103057A0/xx
Publication of IL103057A publication Critical patent/IL103057A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817Toxins
    • A61K47/6819Plant toxins
    • A61K47/6825Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
IL10305792A 1991-09-06 1992-09-04 A method of producing a gene that encodes the plant toxin galonin and a gene created by the method IL103057A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75594991A 1991-09-06 1991-09-06

Publications (2)

Publication Number Publication Date
IL103057A0 IL103057A0 (en) 1993-02-21
IL103057A true IL103057A (en) 1999-09-22

Family

ID=25041367

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10305792A IL103057A (en) 1991-09-06 1992-09-04 A method of producing a gene that encodes the plant toxin galonin and a gene created by the method

Country Status (18)

Country Link
US (1) US5624827A (de)
EP (1) EP0602144B1 (de)
JP (1) JPH06510431A (de)
KR (1) KR100270195B1 (de)
CN (1) CN1047402C (de)
AT (1) ATE173023T1 (de)
AU (1) AU679427B2 (de)
CA (1) CA2115049C (de)
DE (1) DE69227519T2 (de)
DK (1) DK0602144T3 (de)
ES (1) ES2123008T3 (de)
FI (1) FI113547B (de)
IL (1) IL103057A (de)
NO (1) NO317659B1 (de)
NZ (1) NZ244220A (de)
RU (1) RU2142015C1 (de)
WO (1) WO1993005168A1 (de)
ZA (1) ZA926705B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5317009A (en) * 1991-08-26 1994-05-31 New York University Anti-HIV proteins GAP 31, DAP 30 and DAP 32 and therapeutic uses thereof
US6146850A (en) * 1991-11-04 2000-11-14 Xoma Corporation Proteins encoding gelonin sequences
US5621083A (en) * 1991-11-04 1997-04-15 Xoma Corporation Immunotoxins comprising ribosome-inactivating proteins
US5837491A (en) * 1991-11-04 1998-11-17 Xoma Corporation Polynucleotides encoding gelonin sequences
WO1994026910A1 (en) * 1993-05-12 1994-11-24 Xoma Corporation Immunotoxins comprising gelonin and an antibody
US5869619A (en) * 1991-12-13 1999-02-09 Xoma Corporation Modified antibody variable domains
EP1291360A1 (de) * 1991-12-13 2003-03-12 Xoma Corporation Verfahren und Materialien zur Herstellung von modifizierten Antikörper Variablen Domänen und deren therapeutischen Verwendung
US20030166169A1 (en) * 1998-01-16 2003-09-04 Padgett Hal S. Method for constructing viral nucleic acids in a cell-free manner
ZA200305980B (en) 2001-02-12 2007-01-31 Res Dev Foundation Modified proteins, designer toxins, and methods of making thereof
CN1555268B (zh) * 2001-07-17 2013-04-03 研究发展基金会 含促调亡蛋白质的治疗剂
CA2488858A1 (en) * 2002-06-12 2003-12-24 Research Development Foundation Immunotoxin as a therapeutic agent and uses thereof
EP2298806A1 (de) 2002-10-16 2011-03-23 Purdue Pharma L.P. Antikörper, die an zellassoziiertes CA 125/0722P binden, und Verfahren zu deren Anwendung
US20060171919A1 (en) * 2005-02-01 2006-08-03 Research Development Foundation Targeted polypeptides
KR101224828B1 (ko) * 2009-05-14 2013-01-22 (주)바이오니아 siRNA 접합체 및 그 제조방법
US8759036B2 (en) 2011-03-21 2014-06-24 Affymetrix, Inc. Methods for synthesizing pools of probes
WO2014153188A2 (en) 2013-03-14 2014-09-25 Life Technologies Corporation High efficiency, small volume nucleic acid synthesis
LT2768607T (lt) 2011-09-26 2021-12-27 Thermo Fisher Scientific Geneart Gmbh Daugiašulininė plokštelė didelio efektyvumo, mažo tūrio nukleorūgščių sintezei atlikti
US9096840B2 (en) 2012-10-04 2015-08-04 Research Development Foundation Serine protease molecules and therapies
CN107532129B (zh) 2014-12-09 2022-09-13 生命技术公司 高效小体积核酸合成
EP3359669B1 (de) 2015-10-06 2020-05-13 Pierce Biotechnology, Inc. Vorrichtungen und verfahren zur herstellung von proteinen
WO2020001783A1 (en) 2018-06-29 2020-01-02 Thermo Fisher Scientific Geneart Gmbh High throughput assembly of nucleic acid molecules
GB201905303D0 (en) 2019-04-15 2019-05-29 Thermo Fisher Scient Geneart Gmbh Multiplex assembly of nucleic acid molecules
WO2021178809A1 (en) 2020-03-06 2021-09-10 Life Technologies Corporation High sequence fidelity nucleic acid synthesis and assembly

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888415A (en) * 1985-03-04 1989-12-19 Dana-Farber Cancer Institute, Inc. Gelonin immunotoxin
US5024947A (en) * 1987-07-24 1991-06-18 Cetus Corporation Serum free media for the growth on insect cells and expression of products thereby
US5290914A (en) * 1988-04-28 1994-03-01 Mycogen Corporation Hybrid diphtheria-B.t. pesticidal toxins
IE912716A1 (en) * 1990-08-14 1992-02-26 Res Dev Foundation Protein Structure of the Plant Toxin Gelonin

Also Published As

Publication number Publication date
EP0602144A1 (de) 1994-06-22
DE69227519T2 (de) 1999-06-02
FI113547B (fi) 2004-05-14
ZA926705B (en) 1993-04-28
NO317659B1 (no) 2004-11-29
WO1993005168A1 (en) 1993-03-18
NO940736D0 (no) 1994-03-03
EP0602144A4 (de) 1995-03-15
CA2115049C (en) 2003-10-21
AU679427B2 (en) 1997-07-03
RU94034733A (ru) 1996-06-10
AU2547692A (en) 1993-04-05
NZ244220A (en) 1994-12-22
FI941048A0 (fi) 1994-03-04
US5624827A (en) 1997-04-29
CN1047402C (zh) 1999-12-15
EP0602144B1 (de) 1998-11-04
KR100270195B1 (ko) 2001-03-02
CA2115049A1 (en) 1993-03-18
DE69227519D1 (de) 1998-12-10
FI941048A (fi) 1994-03-04
CN1070227A (zh) 1993-03-24
DK0602144T3 (da) 1999-07-19
RU2142015C1 (ru) 1999-11-27
JPH06510431A (ja) 1994-11-24
IL103057A0 (en) 1993-02-21
NO940736L (no) 1994-03-03
ATE173023T1 (de) 1998-11-15
ES2123008T3 (es) 1999-01-01

Similar Documents

Publication Publication Date Title
US5624827A (en) DNA sequences encoding the plant toxin gelonin
EP0170697B1 (de) Toxinkonjugate
US6022950A (en) Hybrid molecules having translocation region and cell-binding region
US5427927A (en) Process for the enzymatic cleavage of recombinant proteins using IgA proteases
US4894443A (en) Toxin conjugates
US5248606A (en) Dna encoding inactive precursor and active forms of maize ribosome inactivating protein
EP0938571B1 (de) Verfahren zur oligomerisation von peptiden
KR870009020A (ko) 하이브리드 인터페론 및 그의 제조방법
Rosenblum et al. Amino acid sequence analysis, gene construction, cloning, and expression of gelonin, a toxin derived from Gelonium multiflorum
JP3362050B2 (ja) 抗微生物ペプチドを大量生産するための方法
WO2017143839A1 (zh) 基于内含肽的药用重组蛋白的合成方法
EP0150572A1 (de) Mikrobielle Expression des Transformationswachstumsfaktors Typ I, analoge Polypeptide hiervon und EGF/TGF-Hybridpolypeptide
JPS63501799A (ja) Cysコドン修飾DNA
JPH07106159B2 (ja) タンパク質抗ガン剤
JP2506322B2 (ja) Grf前駆体をコ―ドするdna
JP2612264B2 (ja) Dna配列体
US6084073A (en) Recombinant ricin toxin
JPS62232387A (ja) 組換リシントキシン
Meadows et al. Targeting of a foreign protein into the thylakoid lumen of pea chloroplasts
US5340732A (en) Antiviral protein
JPH0928380A (ja) ニトリラーゼ遺伝子発現に関わる調節因子およびその遺伝子
JP2003079379A (ja) 成長ホルモンの高発現用dnaおよびその使用
KR20210079235A (ko) Whep 도메인 융합에 의한 목적 단백질의 수용성 증진 방법
Rappuoli et al. Production of large quantities of diphtheria toxoid CRM45
JPH07188290A (ja) アブリンa鎖変異体およびその製造法

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees